TRVI
Trevi Therapeutics, Inc. · Healthcare
President and CEO Jennifer L Good sold $72K of Trevi Therapeutics, Inc.
Sold$71,576
$2.86Price
25,037Shares
−11%Stake
What TRVI did after the filing
- The stock from Wed, May 22 close, $2.65
- +2.6%
- S&P 500, same days
- +5.1%
Measured over 30 trading days, to the Jul 8 close.
Traded Mon, May 20. Filed Wed, May 22, 12:30 PM ET, during the session. Returns use the May 22 close and the Jul 8 close. Not investment advice.